Pure Global COO, DJ Fang, Engages in Key Talks at AstraZeneca's China-Brazil Biomedical Forum to discuss medical innovation.
DJ, COO of Pure Global, was invited to attend the China-Brazil Biomedical Industry Forum held by AstraZeneca on March 12th.
He participated in the event alongside experts from the well-known Brazilian National Research Institute for Public Health (FIOCRUZ) and Chinese innovative entrepreneurs.At this forum, experts and educators at all levels conducted in-depth discussions on medical innovation achievements, the prospects of Brazil's biopharmaceutical industry, and the overseas experiences of AstraZeneca and its partners.
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.
.png)
As 2024 comes to a close, Pure Global proudly reflects on a transformative year marked by substantial growth, cutting-edge innovation, and impactful collaborations.
IVD manufacturers cite the new classification system, detailed definitions for intended purposes, and the need for verification of clinical evidence as key challenges under the IVDR.
(3).png)
On October 23, the European Parliament adopted a resolution revising specific elements of the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Devices Regulation (IVDR). This resolution intends to address ongoing challenges in implementing the regulations by 2025 and to improve patient access to important medical products.
Multilingual documentation presents ongoing compliance and logistical hurdles for MedTech manufacturers. Transla.Ai is an industry-specific translation tool that can accelerate and streamline the translation process.